Two Goals of Therapy in Patients with Stable Angina 1. Improve Prognosis • Measured by “hard endpoints” (i.e. death, MI) 2. Improve Symptoms and Quality of Life • Measured by “soft endpoints” (i.e. angina/QOL scales)
Why Could Revascularizationof Higher- Risk Ischemic Territories Be Important? • Less progression to decreased ventricular function / ischemic cardiomyopathy • Better tolerance of events in other coronary distibutions • Altered rheology within target vessel • Less occlusion?